Granulocyte-macrophage colony-stimulating factor (GM-CSF) allows acceleration and dose intensity increase of CEF chemotherapy: a randomised study in patients with advanced breast cancer.

A randomised study was conducted in 62 patients with advanced breast cancer to assess whether granulocyte-macrophage colony-stimulating factor (GM-CSF) would yield an increase in the dose intensity of a standard-dose CEF regimen through an acceleration of chemotherapy administration. Patients receiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Ardizzoni, A., Venturini, M., Sertoli, M. R., Giannessi, P. G., Brema, F., Danova, M., Testore, F., Mariani, G. L., Pennucci, M. C., Queirolo, P.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1994
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968692/
https://www.ncbi.nlm.nih.gov/pubmed/8297739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968692/
https://www.ncbi.nlm.nih.gov/pubmed/8297739

Ejemplares similares